source
- Industry insiders invited to take Q3 BioPharma Sentiment SurveySignal's Endpoints team is launching the third quarterly BioPharma Sentiment Index (BPSI) survey, a three minute questionnaire that captures industry views. The survey asks participants to share p…
- Industry and patient groups urge FDA to revise master protocol guidanceIndustry groups and patient advocacy organizations have written to the U.S. Food and Drug Administration asking for several revisions to its recently updated draft guidance on master protocols for…